Clinical trials: Intrahepatic Cholestasis of Pregnancy
- Condition Intrahepatic Cholestasis of Pregnancy
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Pregnancy Related
Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy
The study will include participants who were exposed to at least one dose of elafibranor either within the three weeks before conception or at any time during pregnancy (based on estimated last menstrual period [LMP]).
- Trial name
- NCT07556913
- Testing
- Elafibranor
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Ipsen